Many transnational contract research organizations (CROs) planning to open clinical trials in India do so often wary whether they’ve got the required approvals. Their apprehension on securing timely clearances has increased of late, in light of reports suggesting stringencies in the newly imposed regulations for conducting clinical research.  India started revamping the rules governing clinical research following a stricture from the Supreme Court in 2013. The apex judiciary ordered the health ...